Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2011

Open Access 01-12-2011 | Research article

Characteristics of patients with venous thromboembolism and atrial fibrillation in Venezuela

Authors: Dimitri Bennett, Jorge Abate, Page E Abrahamson

Published in: BMC Public Health | Issue 1/2011

Login to get access

Abstract

Background

Studies describing venous thromboembolic event (VTEE) and atrial fibrillation (AF) in South American populations are limited. The aim of this cross-sectional study was to describe the characteristics of Venezuelan patients admitted and treated for these conditions.

Methods

A retrospective medical record review of 1397 consecutive patients admitted to three private hospitals or clinics between January 2000 and December 2005 was performed. Data was collected on demographics, anthropometrics, hospital visit, comorbidities and treatment.

Results

Among 401 VTEE and 996 AF patients, men were more likely to have AF (58%) while more women experienced a VTEE (58%). Most patients were admitted via the emergency room (87%) and had only one event during the study period (83%). Common comorbidities included hypertension (46%), heart failure (17%), diabetes (12%) and congestive heart failure (11%). Characteristics of Venezuelan patients with VTEE and AF are similar to that reported in the literature for other populations.

Conclusions

These results provide background characteristics for future studies assessing risk factors for AF and VTEE in South American populations.
Literature
1.
Lutz W, Sanderson W, Scherbov S: The coming acceleration of global population ageing. Nature. 2008, 451: 716-719. 10.1038/nature06516.CrossRefPubMed
2.
Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ: Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998, 158: 585-93. 10.1001/archinte.158.6.585.CrossRefPubMed
3.
Heit JA: Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005, 3: 1611-1617. 10.1111/j.1538-7836.2005.01415.x.CrossRefPubMed
4.
5.
Næss IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J: Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007, 5: 692-9. 10.1111/j.1538-7836.2007.02450.x.CrossRefPubMed
6.
Oger E: Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost. 2000, 83: 657-60.PubMed
7.
Hooper WC, Holman RC, Heit JA, Cobb N: Venous thromboembolism hospitalizations among American Indians and Alaska Natives. Thromb Res. 2002, 108: 273-8. 10.1016/S0049-3848(03)00058-6.CrossRefPubMed
8.
White RH, Zhou H, Romano PS: Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med. 1998, 128: 737-40.CrossRefPubMed
9.
International Classification of Diseases 10th Revision (ICD-10). 2006, World Health Organization
10.
Dowling NF, Austin H, Dilley A, Whitsett C, Evatt BL, Hooper WC: The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost. 2002, 1: 80-87.CrossRef
11.
Harley CR, Riedel AA, Hauch O, Nelson M, Wygant G, Reynolds M: Anticoagulation therapy in patients with chronic atrial fibrillation: a retrospective claims data analysis. Curr Med Res Opin. 2005, 21: 215-222. 10.1185/030079904X20321.CrossRefPubMed
12.
Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, Kremastinos DTh, Breithardt G, Cokkinos DV, Crijns HJGM: Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe A Report From the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007, 49: 572-7. 10.1016/j.jacc.2006.10.047.CrossRefPubMed
13.
Walker AM, Bennett D: Epidemiology and outcomes in patients with atrial fibrillation in the United States. Heart Rhythm. 2008, 5: 1365-1372. 10.1016/j.hrthm.2008.07.014.CrossRefPubMed
14.
Parkash R, Green MS, Kerr CR, Connolly SJ, Klein GJ, Sheldon R, Talajic M, Dorian P, Humphries KH: The association of left atrial size and occurrence of atrial fibrillation: A prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J. 2004, 148: 649-54. 10.1016/j.ahj.2004.04.029.CrossRefPubMed
15.
Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ: Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009, 28: 401-9. 10.1007/s11239-009-0378-3.CrossRefPubMedPubMedCentral
16.
Arcelus JI, Caprini JA, Monreal M, Suárez C, González-Fajardo J: The management and outcome of acute venous thromboembolism: A prospective registry including 4011 patients. J Vasc Surg. 2003, 38: 916-22. 10.1016/S0741-5214(03)00789-4.CrossRefPubMed
17.
Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C: Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol. 2005, 16: 489-511. 10.1093/annonc/mdi086.CrossRefPubMed
18.
Kirkman MA, Manhattanakul W, Gregson BA, Mendelow AD: The accuracy of hospital discharge coding for hemorrhagic stroke. Acta Neurol Belg. 2009, 109: 114-9.PubMed
19.
Birman-Deych E, Waterman AD, Yan Y, Nilasena DS, Radford MJ, Gage BF: Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. Med Care. 2005, 43: 480-5. 10.1097/01.mlr.0000160417.39497.a9.CrossRefPubMed
20.
Casez P, Labarere J, Sevestre MA, Haddouche M, Courtois X, Mercier S, Lewandowski E, Fauconnier J, François P, Bosson JL: ICD-10 hospital discharge diagnosis codes were sensitive for identifying pulmonary embolism but not deep vein thrombosis. J Clin Epidemiol. 2010, 63: 790-7. 10.1016/j.jclinepi.2009.09.002.CrossRefPubMed
21.
Ghia D, Thomas PR, Cordato D, Worthington JM, Cappelen-Smith C, Griffith N, Hanna I, Hodgkinson SJ, McDougall A, Beran RG: Validation of Emergency and Final Diagnosis Coding in Transient Ischemic Attack: South Western Sydney Transient Ischemic Attack Study. Neuroepidemiology. 2010, 35: 53-58. 10.1159/000310338.CrossRefPubMed
22.
Kokotailo RA, Hill MD: Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke. 2005, 36: 1776-81. 10.1161/01.STR.0000174293.17959.a1.CrossRefPubMed
Metadata
Title
Characteristics of patients with venous thromboembolism and atrial fibrillation in Venezuela
Authors
Dimitri Bennett
Jorge Abate
Page E Abrahamson
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2011
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-11-415

Other articles of this Issue 1/2011

BMC Public Health 1/2011 Go to the issue

Study protocol

The effectiveness of Stepping stones Triple P: the design of a randomised controlled trial on a parenting programme regarding children with mild intellectual disability and psychosocial problems versus care as usual

Research article

Explaining variation in the uptake of HPV vaccination in England

Research article

Community-based intervention to promote breast cancer awareness and screening: The Korean experience

Research article

Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population

Research article

Payment for performance (P4P): any future in Italy?

Study protocol

DiAlert: a lifestyle education programme aimed at people with a positive family history of type 2 diabetes and overweight, study protocol of a randomised controlled trial